文献速递妇产影像介入MR

基于深度学习的方法在子宫肌瘤MR-HIFU治疗后MRI中自动测量子宫、肌瘤及消融体积的开发与验证

Development and validation of a deep learning-based method for automatic measurement of uterus, fibroid, and ablated volume in MRI after MR-HIFU treatment of uterine fibroids.
PubMed 文献 · Eur J Radiol · 2024-07-03

本研究开发并评估了一种深度学习分割算法,用于在MRI上自动测量子宫、子宫肌瘤及无灌注体积(NPV),以自动量化NPV/总肌瘤负荷(NPV/TFL)。基于115例子宫肌瘤患者的MRI扫描与专家手动分割对比,治疗扫描中子宫、NPV和肌瘤的DSC分别为0.90、0.84和0.74,体积ICC分别为1.00、0.99和0.98,NPV/TFL平均差异为5% [-41%, 51%](ICC: 0.66 [0.32, 0.85])。作者认为该算法可自动计算子宫体积、肌瘤负荷和NPV,可能使MR-HIFU治疗后的结果量化比视觉评估更客观,未来研究确认稳健性后可能用于临床实践。

要点

  • 治疗扫描中自动与手动分割的DSC:子宫0.90、NPV 0.84、肌瘤0.74。
  • 自动与手动体积ICC:子宫1.00 [0.99, 1.00]、NPV 0.99 [0.98, 1.00]、肌瘤0.98 [0.95, 0.99]。
  • NPV/TFL自动与手动平均差异5% [-41%, 51%],ICC 0.66 [0.32, 0.85]。

核心结论

  • 该算法可自动计算子宫体积、肌瘤负荷和NPV,与视觉评估相比可能使MR-HIFU治疗子宫肌瘤后的结果量化更客观;未来研究确认稳健性后,该工具可能最终用于临床实践自动测量NPV/TFL。

研究设计与样本

  • 使用115例子宫肌瘤患者的MRI扫描专家手动分割,开发并评估包含三个独立神经网络(每个目标结构一个)的分割流程。

诊断标准与关键数值

  • 治疗扫描中手动与自动分割的DSC:子宫0.90、NPV 0.84、肌瘤0.74。
  • 手动与自动体积ICC:子宫1.00 [0.99, 1.00]、NPV 0.99 [0.98, 1.00]、肌瘤0.98 [0.95, 0.99]。
  • 手动与自动NPV/TFL平均差异5% [-41%, 51%],ICC 0.66 [0.32, 0.85]。

临床应用与阅片要点

  • 分割流程第一步从对比增强T1w扫描分割子宫,用于去除NPV和肌瘤分割中的非子宫背景组织。
  • 随后从仅含子宫的对比增强T1w扫描分割NPV,从仅含子宫的T2w扫描分割肌瘤,并据此计算各结构体积。
  • 作者认为该算法可能使MR-HIFU治疗后的结果量化比视觉评估更客观;未来研究确认稳健性后,该工具可能最终用于临床实践自动测量NPV/TFL。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: The non-perfused volume divided by total fibroid load (NPV/TFL) is a predictive outcome parameter for MRI-guided high-intensity focused ultrasound (MR-HIFU) treatments of uterine fibroids, which is related to long-term symptom relief. In current clinical practice, the MR-HIFU outcome parameters are typically determined by visual inspection, so an automated computer-aided method could facilitate objective outcome quantification. The objective of this study was to develop and evaluate a deep learning-based segmentation algorithm for volume measurements of the uterus, uterine fibroids, and NPVs in MRI in order to automatically quantify the NPV/TFL.

MATERIALS AND METHODS: A segmentation pipeline was developed and evaluated using expert manual segmentations of MRI scans of 115 uterine fibroid patients, screened for and/or undergoing MR-HIFU treatment. The pipeline contained three separate neural networks, one per target structure. The first step in the pipeline was uterus segmentation from contrast-enhanced (CE)-T1w scans. This segmentation was subsequently used to remove non-uterus background tissue for NPV and fibroid segmentation. In the following step, NPVs were segmented from uterus-only CE-T1w scans. Finally, fibroids were segmented from uterus-only T2w scans. The segmentations were used to calculate the volume for each structure. Reliability and agreement between manual and automatic segmentations, volumes, and NPV/TFLs were assessed.

RESULTS: For treatment scans, the Dice similarity coefficients (DSC) between the manually and automatically obtained segmentations were 0.90 (uterus), 0.84 (NPV) and 0.74 (fibroid). Intraclass correlation coefficients (ICC) were 1.00 [0.99, 1.00] (uterus), 0.99 [0.98, 1.00] (NPV) and 0.98 [0.95, 0.99] (fibroid) between manually and automatically derived volumes. For manually and automatically derived NPV/TFLs, the mean difference was 5% [-41%, 51%] (ICC: 0.66 [0.32, 0.85]).

CONCLUSION: The algorithm presented in this study automatically calculates uterus volume, fibroid load, and NPVs, which could lead to more objective outcome quantification after MR-HIFU treatments of uterine fibroids in comparison to visual inspection. When robustness has been ascertained in a future study, this tool may eventually be employed in clinical practice to automatically measure the NPV/TFL after MR-HIFU procedures of uterine fibroids.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Slotman DJ, Bartels LW, Nijholt IM, et al. Development and validation of a deep learning-based method for automatic measurement of uterus, fibroid, and ablated volume in MRI after MR-HIFU treatment of uterine fibroids. Eur J Radiol. 2024. PMID: 38991285. doi:10.1016/j.ejrad.2024.111602

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。